Pathologic significance of Staphylococcus saprophyticus in complicated urinary tract infections. 2001

S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
Department of Urology, Gifu University School of Medicine, Gifu, Japan

OBJECTIVE To determine the pathologic significance of Staphylococcus saprophyticus in complicated urinary tract infections. METHODS We performed a retrospective analysis of specimens demonstrating this organism based on a survey of 9980 urine specimens cultured in our clinic during an 11-year period. Forty-two specimens from 34 patients were positive for S. saprophyticus. RESULTS S. saprophyticus was isolated in 13 women without underlying urologic disease, and their symptoms were compatible with acute cystitis or acute pyelonephritis. S. saprophyticus was isolated from 7 men and 14 women with underlying urologic disease. In most of these 21 patients, S. saprophyticus was thought not to be a true uropathogen but rather a colonizer, because the isolated organism was usually low in numbers and found with a low degree of pyuria, and the hosts were usually asymptomatic. However, 2 patients demonstrating S. saprophyticus colonization developed sepsis after urologic surgery. CONCLUSIONS Although this organism is pathogenic in certain circumstances, suggesting the necessity of preoperative antimicrobial elimination, it is usually a colonizer in complicated urinary tract infections.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
January 1993, European journal of pediatrics,
S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
January 1984, AMB : revista da Associacao Medica Brasileira,
S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
January 1983, Scandinavian journal of infectious diseases,
S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
September 1983, The Journal of urology,
S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
January 1984, Scandinavian journal of infectious diseases,
S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
September 1982, Journal of clinical microbiology,
S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
June 1983, Israel journal of medical sciences,
S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
February 1981, Canadian Medical Association journal,
S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
May 1979, Lakartidningen,
S Ishihara, and S Yokoi, and M Ito, and S Kobayashi, and T Deguchi
June 1982, Clinical pediatrics,
Copied contents to your clipboard!